Skip to main content
logo
Imexpharm Corporation (HOSE:IMP)
Vietnam flag Vietnam · Delayed Price · Currency is VND
35,100
+100 (0.29%)
At close: Nov 3, 2026

Imexpharm Cash Flow Statement

Millions VND. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Jan '25 Jan '24 Dec '22 Dec '21
Net Income
367,400349,138320,862299,556223,540189,095
Depreciation & Amortization
100,393102,976105,63682,64260,38660,412
Other Amortization
2,7221,742----
Loss (Gain) From Sale of Assets
-24,415-19,864-8,759-22,410-19,861-18,628
Other Operating Activities
-43,835-147,657-128,550-32,171-6,126-45,582
Change in Accounts Receivable
-32,720-21,484-83,307-30,53420,136115,759
Change in Inventory
63,11725,990-6,181-260,74952,398-66,129
Change in Accounts Payable
-74,69434,18720,27825,48139,580-2,831
Change in Other Net Operating Assets
30,427-270,857-3,711-101,3517,018-2,159
Operating Cash Flow
388,39554,171216,268-39,535378,603234,881
Operating Cash Flow Growth
--74.95%--61.19%221.08%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Jan '25 Jan '24 Dec '22 Dec '21
Capital Expenditures
-37,788-26,879-96,771-63,530-99,353-52,857
Sale of Property, Plant & Equipment
220.231,1274,8322,533582.738,655
Investment in Securities
-70,102-70,102-42,935118,300-118,327-244,945
Other Investing Activities
20,20519,2707,67521,81717,79410,106
Investing Cash Flow
-175,260-76,584-127,19979,121-199,304-83,142

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Jan '25 Jan '24 Dec '22 Dec '21
Short-Term Debt Issued
---229,73959,803-
Long-Term Debt Issued
-666,889387,994--324,785
Total Debt Issued
266,647666,889387,994229,73959,803324,785
Short-Term Debt Repaid
----275,298--
Long-Term Debt Repaid
--540,232-351,294--231,514-190,282
Total Debt Repaid
-427,988-540,232-351,294-275,298-231,514-190,282
Net Debt Issued (Repaid)
-161,341126,65836,700-45,558-171,711134,503
Common Dividends Paid
-92,405-77,004-70,005-66,672-100,007-100,007
Financing Cash Flow
-253,74649,653-33,305-112,230-271,71834,496

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Jan '25 Jan '24 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-43.77-30.6619.18-0.59-9.19-230.63
Net Cash Flow
-40,65627,21055,783-72,645-92,428186,004

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Jan '25 Jan '24 Dec '22 Dec '21
Free Cash Flow
350,60727,292119,497-103,064279,250182,024
Free Cash Flow Growth
--77.16%--53.41%-
Free Cash Flow Margin
15.29%1.12%5.42%-5.17%16.99%14.37%
Free Cash Flow Per Share
2276.54177.21775.91-669.211813.191181.89
Levered Free Cash Flow
343,769380,110145,454-69,934274,201211,391
Unlevered Free Cash Flow
351,332390,423147,635-66,162276,573214,826

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Jan '25 Jan '24 Dec '22 Dec '21
Cash Interest Paid
16,38216,3823,4916,7004,4754,227
Cash Income Tax Paid
93,282101,01470,80683,99259,62445,310
Change in Working Capital
-13,870-232,165-72,921-367,153120,66449,583